Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proteostasis Deficiencies”

1,740 trials

Showing 20 of 1,740 results

Early research (Phase 1)Ended earlyNCT00030381
What this trial is testing

Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
National Cancer Institute (NCI) 22
Not applicableLooking for participantsNCT05632757
What this trial is testing

Anticipated Patient and Caregiver Burden

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique Hopitaux De Marseille 126
Testing effectiveness (Phase 2)Study completedNCT00003853
What this trial is testing

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT00956501
What this trial is testing

Assessment of Postural Orientation and Equilibrium In Early Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Wake Forest University Health Sciences 35
Not applicableStudy completedNCT02496312
What this trial is testing

Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.

Who this might be right for
ApathyBehaviorFrontotemporal Dementia
Institut National de la Santé Et de la Recherche Médicale, France 14
Large-scale testing (Phase 3)Ended earlyNCT04973137
What this trial is testing

Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Prothena Biosciences Ltd. 208
Not applicableStudy completedNCT04068077
What this trial is testing

Application of High Resolution Optical Coherence Tomography in Skin Disease: Amyloidosis and Differential Diagnosis

Who this might be right for
Amyloidosis
Taipei Veterans General Hospital, Taiwan 50
Not applicableWithdrawnNCT02664571
What this trial is testing

Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis

Who this might be right for
Amyloid Cerebral AngiopathyAlzheimer Disease
Centre Hospitalier Universitaire de Nīmes
Large-scale testing (Phase 3)Ended earlyNCT06111014
What this trial is testing

Continuation Study for Latozinemab

Who this might be right for
Neurodegenerative Diseases
Alector Inc. 17
Post-approval studies (Phase 4)Study completedNCT00800709
What this trial is testing

Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 26
Large-scale testing (Phase 3)Looking for participantsNCT06008249
What this trial is testing

Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Stichting TRICALS Foundation 171
Not applicableStudy completedNCT03371706
What this trial is testing

Communication Bridge 2

Who this might be right for
Primary Progressive Aphasia
University of Chicago 190
Not applicableUnknownNCT01856699
What this trial is testing

Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy

Who this might be right for
Intracerebral HemorrhageCerebral Amyloid AngiopathyIschemic Stroke
Ludwig-Maximilians - University of Munich 302
Testing effectiveness (Phase 2)WithdrawnNCT05486481
What this trial is testing

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Who this might be right for
AL AmyloidosisLight Chain (AL) AmyloidosisSystemic Light Chain Disease
Alfred Chung, MD
Not applicableLooking for participantsNCT07006571
What this trial is testing

At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis

Who this might be right for
ALSALS (Amyotrophic Lateral Sclerosis)
University of Trieste 40
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Post-approval studies (Phase 4)Study completedNCT04828993
What this trial is testing

The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients

Who this might be right for
Transthyretin Amyloid Polyneuropathy (ATTR-PN)
Pfizer 15
Large-scale testing (Phase 3)Study completedNCT01933321
What this trial is testing

Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Hospital Universitario Dr. Jose E. Gonzalez 14
Not applicableStudy completedNCT02338427
What this trial is testing

Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis

Who this might be right for
Amyloidosis
Centre Hospitalier Departemental Vendee 140
Testing effectiveness (Phase 2)Study completedNCT00204464
What this trial is testing

Study of the Effects Strengthening Exercises in Individuals With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Saskatchewan 40
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation